Bernzott Capital Advisors, an investment management firm, published its “US Small Cap Value Fund” third quarter 2021 investor letter – a copy of which can be downloaded here. The portfolio fell -3.0% (gross) and -3.1% (net) during 3Q, in line with the Russell 2000 Value’s decline of -3.0%, and somewhat more than the Russell 2500 Value’s drop of -2.1%. You can take a look at the fund’s top 5 holdings to have an idea about their best picks for 2021.
Bernzott Capital Advisors, in its Q3 2021 investor letter, mentioned Medpace Holdings, Inc. (NASDAQ: MEDP) and discussed its stance on the firm. Medpace Holdings, Inc. is a Cincinnati, Ohio-based clinical research-based drug and medical device development with an $8 billion market capitalization. MEDP delivered a 60.34% return since the beginning of the year, while its 12-month returns are up by 94.51%. The stock closed at $221.87 per share on November 12, 2010.
Here is what Bernzott Capital Advisors has to say about Medpace Holdings, Inc. in its Q3 2021 investor letter:
“Medpace (MEDP): We exited the position as the stock reached our estimate of fair value after appreciating nearly six times from our initial purchase price over four years ago.”
national-cancer-institute–Ln-tYivJM4-unsplash
Based on our calculations, Medpace Holdings, Inc. (NASDAQ: MEDP) was not able to clinch a spot in our list of the 30 Most Popular Stocks Among Hedge Funds. MEDP was in 24 hedge fund portfolios at the end of the first half of 2021, compared to 21 funds in the previous quarter. Medpace Holdings, Inc. (NASDAQ: MEDP) delivered a 28.89% return in the past 3 months.
Hedge funds’ reputation as shrewd investors has been tarnished in the last decade as their hedged returns couldn’t keep up with the unhedged returns of the market indices. Our research has shown that hedge funds’ small-cap stock picks managed to beat the market by double digits annually between 1999 and 2016, but the margin of outperformance has been declining in recent years. Nevertheless, we were still able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by 115 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that underperformed the market by 10 percentage points annually between 2006 and 2017. Interestingly the margin of underperformance of these stocks has been increasing in recent years. Investors who are long the market and short these stocks would have returned more than 27% annually between 2015 and 2017. We have been tracking and sharing the list of these stocks since February 2017 in our quarterly newsletter.
At Insider Monkey, we scour multiple sources to uncover the next great investment idea. Recently we came across a high-growth stock that has tons of hidden assets and is trading at an extremely cheap valuation. We go through lists like the 10 best growth stocks to buy to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage.
Disclosure: None. This article is originally published at Insider Monkey.
